Log In
Print this Print this

NeuroVax (IR208)

  Manage Alerts
Collapse Summary General Information
Company Immune Response BioPharma Inc.
DescriptionVaccine containing mixture of BV5S2, BV6S5 and BV13S1 peptides
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing-remitting (RR) or secondary progressive multiple sclerosis (SPMS); Treat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today